Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease
Sponsor: Hanyang University
Listed as NCT03983408, this NA trial focuses on Korean Red Ginseng and Rheumatic Diseases and remains ongoing. Sponsored by Hanyang University, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2019 — Jul 2020 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hanyang University
- The Korean Society of Ginseng
For direct contact, visit the study record on ClinicalTrials.gov .